Publication | Open Access

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

UrologyGenitourinary CancerMedicineFirst-line TreatmentCancer TreatmentPhase 2OncologyRadiation OncologyCisplatin-ineligible PatientsMolecular Oncology